Testosterone and Estrone Increase From the Age of 70 Years: Findings From the Sex Hormones in Older Women Study

J Clin Endocrinol Metab. 2019 Dec 1;104(12):6291-6300. doi: 10.1210/jc.2019-00743.

Abstract

Context: There is a lack of understanding of what is normal in terms of sex steroid levels in older women.

Objective: To determine whether sex steroid levels vary with age in and establish reference ranges for women >70 years of age.

Design and setting: Cross-sectional, community-based study.

Participants: Included 6392 women ≥70 years of age.

Main outcome measures: Sex steroids measured by liquid chromatography-tandem mass spectrometry. A reference group, to establish sex steroid age-specific reference ranges, excluded women using systemic or topical sex steroid, antiandrogen or glucocorticoid therapy, or an antiglycemic agent.

Results: The reference group of 5326 women had a mean age of 75.1 (±4.2) years, range of 70 to 94.7 years. Median values (range) were 181.2 pmol/L (3.7 to 5768.9) for estrone (E1), 0.38 nmol/L (0.035 to 8.56) for testosterone (T), 2.60 nmol/L (0.07 to 46.85) for dehydroepiandrosterone (DHEA), and 41.6 nmol/L (2.4 to 176.6) for SHBG. Estradiol and DHT were below method sensitivity in 66.1% and 72.7% of the samples, respectively. Compared with women aged 70 to 74 years, women aged ≥85 years had higher median levels of E1 (11.7%, P = 0.01), T (11.3%, P = 0.02), and SHBG (22.7%, P < 0.001) and lower DHEA (30% less, P < 0.001). Women with overweight and obesity had higher E1 (P < 0.001) and T (P < 0.03) and lower SHBG (P < 0.001) than did women with normal body mass index. Smokers had 17.2% higher median T levels (P = 0.005).

Conclusion: From the age of 70 years, T and E1 increase with age, despite a steady decline in DHEA. Whether E1 and T are biomarkers for longevity or contribute to healthy aging merits investigation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging*
  • Biomarkers / blood*
  • Community-Based Participatory Research
  • Cross-Sectional Studies
  • Dehydroepiandrosterone / blood*
  • Estrone / blood*
  • Female
  • Follow-Up Studies
  • Humans
  • Obesity / blood*
  • Obesity / physiopathology
  • Overweight / blood*
  • Overweight / physiopathology
  • Prognosis
  • Testosterone / blood*

Substances

  • Biomarkers
  • Estrone
  • Testosterone
  • Dehydroepiandrosterone